Miyabashira Asuka — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Miyabashira Asuka has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Based on the SEC filing context, Miyabashira Asuka serves as President of Takeda Pharmaceutical Company Limited's Japan Pharma Business Unit. In this capacity, she leads Takeda's pharmaceutical operations in Japan and directs regional strategy and business execution within the Japan market. This information reflects the position as of the most recent SEC filing dated 2026-07-06.
Role
President, Japan Pharma B.U.
Notability
65/100
Board memberships
Takeda Pharmaceutical Company Limited
Awards & honors
Leading role as President of Takeda's Japan Pharma BU (as of 2026-07-06)
Oversees strategic direction and operational leadership for Takeda's Japan pharmaceutical business
Based on the SEC filing context, Miyabashira Asuka serves as President of Takeda Pharmaceutical Company Limited's Japan Pharma Business Unit. In this capacity, she leads Takeda's pharmaceutical operations in Japan and directs regional strategy and business execution within the Japan market. This information reflects the position as of the most recent SEC filing dated 2026-07-06…
How many SEC Form 4 filings has Miyabashira Asuka submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Miyabashira Asuka's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
